2024 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (ICKSH 2024)-1ÀÏ : 2024-03-28
±³À°ÀÏÀÚ : 2024-03-28
±³À°Àå¼Ò : ±×·£µå¿öÄ¿ÈúÈ£ÅÚ
±³À°ÁÖÁ¦ : 2024 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (ICKSH 2024)-1ÀÏ
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ : hematology@kams.or.kr
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú
Âü¼®¿¹»óÀÎ : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 45ºÐ
¼¼ºÎ¼ö°·á : 300,000¿ø
ºñ°í 2¿ù 28ÀϱîÁö ȸ¿ø 100,000¿ø / ºñȸ¿ø 200,000¿ø3¿ù 1ÀϺÎÅÍ È¸¿ø 200,000¿ø / ºñȸ¿ø 300,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03¿ù 28ÀÏ ROOM1 09:00~09:25 Prospective studies for NK/T-cell lymphoma in Asia Seok Jin Kim(Sungkyunkwan University Korea)
±³À°½Ã°£ 03¿ù 28ÀÏ ROOM1 09:25~09:50 Chronic active EBV disease: Our challenge to elucidate the pathogenesis Ayako Arai(St. Marianna University Japan)
±³À°½Ã°£ 03¿ù 28ÀÏ ROOM1 09:50~10:15 NK lymphoma genomics Weili Zhao(Shanghai Jiao Tong University China)
±³À°½Ã°£ 03¿ù 28ÀÏ ROOM1 10:30~11:15 Somatic mutations and clonal dynamics in human blood cells Peter J. Campbell(Wellcome Sanger Institute UK)
±³À°½Ã°£ 03¿ù 28ÀÏ ROOM1 11:15~12:00 Lab-on-a-chip in hematology Chong H. Ahn(University of Cincinnati USA)
±³À°½Ã°£ 03¿ù 28ÀÏ ROOM2 12:15~13:05 The ultimate value of C5 inhibitors in the evolving treatment landscape of PNH( paroxysmal nocturnal hemoglobinuria) Sung-hyun Kim(Dong-A University Korea)
±³À°½Ã°£ 03¿ù 28ÀÏ ROOM2 13:50~15:20 Prognostic value of end-of-treatment [18F]FDG PET/CT in newly diagnosed patients with primary central nervous system lymphoma who respond to first-line treatment with high-dose methotrexate-based regimen Hyungwoo Cho(University of Ulsan Korea)
±³À°½Ã°£ 03¿ù 28ÀÏ ROOM2 15:30~15:55 Approaches to treat people with hemophilia: What¡¯s new and what¡¯s not? Leonard Valentino(The National Bleeding Disorders Foundation USA)
±³À°½Ã°£ 03¿ù 28ÀÏ ROOM2 15:55~16:20 Prospects and challenges of gene therapy Alok Srivastava(Christian Medical College India)
±³À°½Ã°£ 03¿ù 28ÀÏ ROOM2 16:20~16:45 Exploring personalized tailored hemophilia treatment Jeong-A Park(Inha University Korea)
±³À°½Ã°£ 03¿ù 28ÀÏ ROOM2 16:55~17:25 Molecular alterations and clinical implications in MDS(myelodysplastic syndrome) Yasushi Miyazaki(Nagasaki University Japan)
±³À°½Ã°£ 03¿ù 28ÀÏ ROOM2 17:25~17:55 Recent advances and future therapeutic strategies in MDS((myelodysplastic syndrome) Garcia-Manero Guillermo(The University of Texas USA)
±³À°½Ã°£ 03¿ù 28ÀÏ ROOM2 17:55~18:20 Current diagnostic challenges of MDS(myelodysplastic syndrome) In-Suk Kim(Pusan National University Korea)